1. Home
  2. LCTX vs NATR Comparison

LCTX vs NATR Comparison

Compare LCTX & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Logo Nature's Sunshine Products Inc.

NATR

Nature's Sunshine Products Inc.

HOLD

Current Price

$21.58

Market Cap

389.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCTX
NATR
Founded
1990
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
389.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LCTX
NATR
Price
$1.65
$21.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$4.25
$21.33
AVG Volume (30 Days)
1.3M
105.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.80
Revenue
$10,816,000.00
$474,542,000.00
Revenue This Year
$6.32
$7.30
Revenue Next Year
$124.49
$3.44
P/E Ratio
N/A
$26.88
Revenue Growth
24.05
6.62
52 Week Low
$0.37
$11.01
52 Week High
$2.09
$24.12

Technical Indicators

Market Signals
Indicator
LCTX
NATR
Relative Strength Index (RSI) 43.84 55.86
Support Level $1.63 $21.42
Resistance Level $1.77 $23.03
Average True Range (ATR) 0.08 0.82
MACD -0.01 -0.25
Stochastic Oscillator 16.67 28.03

Price Performance

Historical Comparison
LCTX
NATR

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

Share on Social Networks: